Table 1.

Baseline Characteristics of the Cohort (n=49 Subjects)

Age at presentation for pubertal suppression, years, mean±SD
Total cohort	11.6±2.4
Group A (n=25)	11.7±1.6
Group B (n=15)	12.9±1.7
Group C (n=2)	14.7±2.2
Group D (n=7)	7.9±2.4
Tanner stage 2–5, mean, (range)	2.9 (2–5)
Group A (n=25)	2.5 (2–5)
Group B (n=15)	3.1 (2–5)
Group C (n=2)	5
Group D (n=7)	3.0 (2–5)
Race, n (%)
White	29 (59.2)
Black/AA	3 (6.1)
Asian	7 (14.3)
Multiracial	2 (4.1)
Other/unspecified	8 (16.3)
Ethnicity, n (%)
Non-Hispanic/Latino	34 (69.4)
Hispanic/Latino	10 (20.4)
Declined to answer	5 (10.2)
Indication for treatment
GD, n (%)	42 (85.7)
AFAB	22 (52.4)
AMAB	20 (47.6)
Central precocious puberty, n (%)	7 (14.2)
AFAB	5 (71.4)
AMAB	2 (28.6)

AFAB, assigned female at birth; AMAB, assigned male at birth; GD, gender dysphoria; SD, standard deviation.